Easy gang. Don't forget that the Nasdaq went up big today and this stock was over due for a modest lift.
It seems that we have lost a lot of interesting posters here after many years of disappointing progress on various drugs in development. When the stocks does start to move The BOD & Mr. Junis add more outstanding shares to water down the value and give themselves perks that are not deserved. When they do present at various medical conferences. their pitches are weak. Hopefully, this company can be led by someone like Mr Lambert and he will throw the bums out, on the road to leading IMGN with their great techknology.
Only a high school graduate
That could be Simon Barsinister
Its Hodgkin Lymphoma treatment, Adcetris, reached record sales levels, beating its prior year total by 32%.And phase 111 trials for Aethera, a progression-free survival extension test, proved positive at the top line. It seems likely that momentum for SGEN will persist
The performance by the company's flagship treatment augurs well for long term growth potential. Coupled with the presence of an extensive pipeline of Hogkins Lymphoma applications, ADCETRIS ought to help Seattle Genetics achieve profitability within the next five years (Young investors check it out).
Who is this Hulking Peasant? Like the Dems never told any lies during the campaign, & I'm the Tooth Fairy (-: or was that Harry Reid?
Today IMGN went up $1.16. Bet you $10,000. that tomorrow when it goes back down, Oppy will post several "Debbie Downer Messages" on Investor Village. He is so consistent and must have high bold pressure
That is easy to understand. That old guy Oppy keeps hammering away at the same thing. He should get out and smell the roses and if he wants to return it could be more rewarding.
This must be the "House of Fear". There has not been a message posted for several days. Nobody knows where the hell this stock is headed, but one thing is clear, they have some goodies that can be bought by the big boys.
I voted all of 17,000 shares against all Board members, additional shares hand outs etc. Like all of us here It's time that these people go to work.or get lost.
These American boys think they sooooo shmarrrtt
You hit the nail on the head. Thank you for your many fine posts. Many of us will probably go down with the ship, The CEO and his pitiful BOD are milking this cow into the twilight zone. Kadcyla could have been a great rocket for this company.
Have a feeling that one of these days Junus and his gang may feel it's time to sign in. Some of these bio-techs cruise along for years with out any ownership of their stocks when all of a sudden It's high time to get to hymn time. It seems that Kadcyla could be added to many cancers and If it happens all hell will fall upon shorts.
Daaaaaaaaaaaa, what the hell do we know. Many of us are 20 years plus on this break through drug.....who can figure this out. Key people have left the company with only Mr. Lambert left from the original crew. No board member has taken out his own purchase shares unless they were gifts....options etc. \\Boe
I agree with you that IMGN is being wasted. Down through the years I have $ cost average and have a 6.25 Avg on 18,000 shares. The problem is I don't trust the CEO and the board since the only shares they buy are handed down to them.